Recursion Pharmaceuticals and Exscientia announce merger to transform drug development

Pallavi Madhiraju- August 10, 2024 0

Recursion Pharmaceuticals Inc. (Nasdaq: RXRX) and Exscientia plc (Nasdaq: EXAI) have announced a landmark merger, combining their strengths to form a formidable entity in drug ... Read More

Tempus and AstraZeneca expand collaboration to enhance cancer care with AI

Pallavi Madhiraju- June 2, 2024 0

Tempus, a pioneer in artificial intelligence and precision medicine, has announced an expansion of its collaboration with pharmaceutical giant AstraZeneca. This enhanced partnership focuses on ... Read More

Lantern Pharma announces collaboration with Oregon Therapeutics to advance AI-driven cancer drug development

Pallavi Madhiraju- May 6, 2024 0

Lantern Pharma Inc. (NASDAQ: LTRN) announced a strategic collaboration with French biotech company Oregon Therapeutics to enhance the development of XCE853, a first-in-class protein disulfide ... Read More

Diamyd Medical advances Diamyd with Phase 3 trial for Type 1 Diabetes

Pallavi Madhiraju- April 14, 2024 0

Diamyd Medical has achieved a significant milestone in its pioneering Phase 3 trial, DIAGNODE-3, of Diamyd in Type 1 Diabetes, marking the successful enrollment of ... Read More

APx Acquisition announces merger with OmnigenicsAI and MultiplAI Health

Pallavi Madhiraju- March 27, 2024 0

In a landmark transaction for the biotechnology and AI industries, APx Acquisition Corp. I (NASDAQ: APXI), OmnigenicsAI Corp, and MultiplAI Health Ltd have signed a ... Read More

Microsoft and NVIDIA forge ahead with AI and cloud computing in healthcare

Pallavi Madhiraju- March 19, 2024 0

Microsoft Corp. is expanding its longstanding partnership with NVIDIA, setting a new benchmark in the integration of generative AI, cloud, and accelerated computing within the ... Read More

Zephyr AI announces $111m Series A to advance AI in precision medicine

Pallavi Madhiraju- March 14, 2024 0

Zephyr AI, Inc., a pioneering healthcare technology company committed to enhancing precision medicine through fast and explainable Artificial Intelligence (AI) solutions, has successfully closed a ... Read More

CureMatch, Spesana forge partnership to revolutionize precision medicine

Pallavi Madhiraju- March 11, 2024 0

In a groundbreaking development for the healthcare industry, CureMatch and Spesana have announced a strategic partnership aimed at advancing precision medicine and transforming patient care ... Read More

Owkin and AWS join forces to transform precision medicine

Pallavi Madhiraju- February 12, 2024 0

Owkin, a pioneering TechBio company known for combining human and artificial intelligence to tailor treatments for individual patients, has announced a strategic collaboration with Amazon ... Read More

Owkin and AWS forge path to precision medicine with strategic collaboration

Pallavi Madhiraju- February 10, 2024 0

Owkin, a pioneering TechBio company, has announced a strategic collaboration with Amazon Web Services (AWS) to innovate in the field of drug discovery, enhance clinical ... Read More